# CIZ1

## Overview
CIZ1 (CDKN1A interacting zinc finger protein 1) is a gene that encodes a nuclear protein involved in the regulation of DNA replication and cell cycle progression. The CIZ1 protein is characterized by its zinc finger motifs, which facilitate interactions with DNA and other proteins, categorizing it as a nuclear matrix-associated protein. It plays a pivotal role in the initiation of DNA replication by coordinating the recruitment of cyclin-dependent kinases and cyclins to chromatin, thereby ensuring proper cell cycle progression. CIZ1's interactions with key regulatory proteins, such as cyclin E, cyclin A, and p21, underscore its importance in maintaining genomic stability. Alterations in CIZ1 expression and mutations have been linked to various diseases, including cancers and neurodegenerative disorders, highlighting its clinical significance (Coverley2005Ciz1; Copeland2010Ciz1; Khan2018DNA).

## Structure
The CIZ1 protein is composed of 898 amino acids and features several distinct structural domains. Its primary structure includes two glutamine-rich domains (QD1 and QD2), three C2H2-type zinc finger motifs, an acidic domain, and an MH3 domain. The QD1 domain is characterized by polyglutamine and leucine repeats, while QD2 contains 23 QXQ repeats and two tandem glutamine-rich motifs (Mitsui1999Cloning). The zinc finger motifs are involved in DNA binding and protein-protein interactions, although they show weak similarity to the Protein on Ecdysone Puffs (PEP) (Mitsui1999Cloning).

The C-terminal region of CIZ1 includes a matrin 3 domain, which is crucial for its association with the nuclear matrix and may interact with nucleic acids (Ainscough2007Cterminal). This region also contains a SAP or SAF motif, which is associated with nucleic acid binding (Ainscough2007Cterminal). Alternative splicing of CIZ1 results in multiple isoforms, including variants that lack key functional domains, such as the MH3 domain, affecting their nuclear matrix attachment and interaction capabilities (Swarts2018CIZ1F).

CIZ1 is subject to post-translational modifications, including phosphorylation at multiple cyclin-dependent kinase sites, which may influence its activity and role in DNA replication and cell cycle regulation (Rahman2010Differential).

## Function
CIZ1 (CDKN1A interacting zinc finger protein 1) is a nuclear protein that plays a crucial role in DNA replication and cell cycle regulation in healthy human cells. It interacts with several key proteins involved in cellular proliferation, including cyclin E, cyclin A, CDK2, and p21, facilitating the spatial and temporal coordination of DNA replication (Copeland2010Ciz1; Pauzaite2016Emerging). CIZ1 is involved in the initiation of DNA replication by promoting the recruitment of cyclin A-CDK2 to chromatin during the late G1 phase, which is essential for the transition into the S phase (Copeland2010Ciz1; Pauzaite2016Emerging).

CIZ1 is associated with the nuclear matrix, where it helps localize and recruit DNA replication complexes, ensuring efficient initiation of DNA replication (Copeland2015Cyclin; Coverley2005Ciz1). It acts as a kinase sensor, modulating its interactions with cyclin-A-CDK2 based on its phosphorylation status, which regulates the initiation of DNA replication and prevents re-replication (Copeland2015Cyclin). This regulatory mechanism ensures that DNA replication occurs once per cell cycle, maintaining genomic stability (Pauzaite2016Emerging). CIZ1's activity is crucial for cell cycle progression, as its inhibition leads to a significant reduction in S phase entry (Coverley2005Ciz1).

## Clinical Significance
Mutations and alterations in the expression of the CIZ1 gene have been implicated in various diseases, particularly cancers and neurodegenerative disorders. In breast cancer, the C-terminal anchor domain (AD) of CIZ1 is elevated in early-stage tumors, correlating with chromatin deprotection and up-regulation of cancer-associated gene clusters. This suggests that CIZ1 AD can disrupt established gene expression patterns, potentially leading to epigenetic instability in tumors (Coverley2024Epigenetic; Turvey2023Dominant). 

CIZ1 is also associated with cervical dystonia, a neurological movement disorder. Specific mutations, such as c.790A>G and c.1730C>T, have been identified in patients with this condition, affecting splicing and protein function (Xiao2012Mutations). 

In hepatocellular carcinoma, CIZ1 is upregulated, promoting cell growth and migration, which suggests its involvement in cancer progression (Wu2015CIZ1). 

CIZ1 deficiency in aged mice has been linked to neurodegenerative phenotypes, including increased DNA damage, neuroinflammation, and cognitive deficits, indicating its role in age-related neurological deterioration (Khan2018DNA). 

These findings highlight the clinical significance of CIZ1 in various pathological conditions.

## Interactions
CIZ1 (CDKN1A interacting zinc finger protein 1) is involved in several key interactions with proteins and nucleic acids that influence DNA replication and cell cycle regulation. CIZ1 interacts with cyclins E and A through distinct cyclin-binding motifs, playing a crucial role in coordinating their sequential activities during DNA replication. Cyclin A displaces cyclin E from CIZ1, which is essential for DNA replication initiation (Copeland2010Ciz1). The interaction with cyclin A is particularly dependent on a specific fragment of CIZ1, known as fragment 80 (Copeland2010Ciz1).

CIZ1 also interacts with the CDK inhibitor protein p21 (CDKN1A), specifically binding to its N-terminal CDK binding region. This interaction is disrupted by the overexpression of CDK2, suggesting a regulatory role in cell cycle progression (Mitsui1999Cloning). Additionally, CIZ1 forms a stable complex with DHX9, an RNA/DNA helicase, and their colocalization in the nucleolus is cell cycle regulated, particularly during the S-phase (Thacker2020Identification).

CIZ1 is also associated with the nuclear matrix and interacts with Xist RNA, playing a role in the localization of Xist RNA to the inactive X-chromosome territory (Sunwoo2017Repeat; RidingsFigueroa2017The). These interactions highlight CIZ1's multifaceted role in DNA replication, cell cycle regulation, and chromatin organization.


## References


1. (Coverley2024Epigenetic) Epigenetic deprogramming driven by disruption of CIZ1-RNA nuclear assemblies in early-stage breast cancers. This article has 0 citations.

[2. (Ainscough2007Cterminal) Justin F.-X. Ainscough, Faisal Abdel Rahman, Heather Sercombe, Alicia Sedo, Bjorn Gerlach, and Dawn Coverley. C-terminal domains deliver the dna replication factor ciz1 to the nuclear matrix. Journal of Cell Science, 120(1):115–124, January 2007. URL: http://dx.doi.org/10.1242/jcs.03327, doi:10.1242/jcs.03327. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.03327)

[3. (Pauzaite2016Emerging) Tekle Pauzaite, Urvi Thacker, James Tollitt, and Nikki Copeland. Emerging roles for ciz1 in cell cycle regulation and as a driver of tumorigenesis. Biomolecules, 7(1):1, December 2016. URL: http://dx.doi.org/10.3390/biom7010001, doi:10.3390/biom7010001. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom7010001)

[4. (Xiao2012Mutations) Jianfeng Xiao, Ryan J. Uitti, Yu Zhao, Satya R. Vemula, Joel S. Perlmutter, Zbigniew K. Wszolek, Demetrius M. Maraganore, Georg Auburger, Barbara Leube, Katja Lehnhoff, and Mark S. LeDoux. Mutations in ciz1 cause adult onset primary cervical dystonia. Annals of Neurology, 71(4):458–469, March 2012. URL: http://dx.doi.org/10.1002/ana.23547, doi:10.1002/ana.23547. This article has 120 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/ana.23547)

[5. (Wu2015CIZ1) Jinsheng Wu, Liu Lei, Dianhua Gu, Hui Liu, and Shaochuang Wang. Ciz1 is upregulated in hepatocellular carcinoma and promotes the growth and migration of the cancer cells. Tumor Biology, 37(4):4735–4742, October 2015. URL: http://dx.doi.org/10.1007/s13277-015-4309-y, doi:10.1007/s13277-015-4309-y. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s13277-015-4309-y)

[6. (Khan2018DNA) Mohammad Moshahid Khan, Jianfeng Xiao, Damini Patel, and Mark S. LeDoux. Dna damage and neurodegenerative phenotypes in aged ciz1 null mice. Neurobiology of Aging, 62:180–190, February 2018. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2017.10.014, doi:10.1016/j.neurobiolaging.2017.10.014. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2017.10.014)

[7. (Copeland2015Cyclin) Nikki A. Copeland, Heather E. Sercombe, Rosemary H. C. Wilson, and Dawn Coverley. Cyclin a/cdk2 phosphorylation of ciz1 blocks replisome formation and initiation of mammalian dna replication. Journal of Cell Science, January 2015. URL: http://dx.doi.org/10.1242/jcs.161919, doi:10.1242/jcs.161919. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.161919)

[8. (Copeland2010Ciz1) Nikki A. Copeland, Heather E. Sercombe, Justin F. X. Ainscough, and Dawn Coverley. Ciz1 cooperates with cyclin-a–cdk2 to activate mammalian dna replication in vitro. Journal of Cell Science, 123(7):1108–1115, April 2010. URL: http://dx.doi.org/10.1242/jcs.059345, doi:10.1242/jcs.059345. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.059345)

[9. (RidingsFigueroa2017The) Rebeca Ridings-Figueroa, Emma R. Stewart, Tatyana B. Nesterova, Heather Coker, Greta Pintacuda, Jonathan Godwin, Rose Wilson, Aidan Haslam, Fred Lilley, Renate Ruigrok, Sumia A. Bageghni, Ghadeer Albadrani, William Mansfield, Jo-An Roulson, Neil Brockdorff, Justin F.X. Ainscough, and Dawn Coverley. The nuclear matrix protein ciz1 facilitates localization of xist rna to the inactive x-chromosome territory. Genes &amp; Development, 31(9):876–888, May 2017. URL: http://dx.doi.org/10.1101/gad.295907.117, doi:10.1101/gad.295907.117. This article has 107 citations.](https://doi.org/10.1101/gad.295907.117)

[10. (Swarts2018CIZ1F) Dorian R.A. Swarts, Emma R. Stewart, Gillian S. Higgins, and Dawn Coverley. Ciz1-f, an alternatively spliced variant of the dna replication protein ciz1 with distinct expression and localisation, is overrepresented in early stage common solid tumours. Cell Cycle, 17(18):2268–2283, September 2018. URL: http://dx.doi.org/10.1080/15384101.2018.1526600, doi:10.1080/15384101.2018.1526600. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/15384101.2018.1526600)

[11. (Rahman2010Differential) Faisal A Rahman, Naveed Aziz, and Dawn Coverley. Differential detection of alternatively spliced variants of ciz1 in normal and cancer cells using a custom exon-junction microarray. BMC Cancer, September 2010. URL: http://dx.doi.org/10.1186/1471-2407-10-482, doi:10.1186/1471-2407-10-482. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2407-10-482)

[12. (Thacker2020Identification) Urvi Thacker, Tekle Pauzaite, James Tollitt, Maria Twardowska, Charlotte Harrison, Adam Dowle, Dawn Coverley, and Nikki A. Copeland. Identification of dhx9 as a cell cycle regulated nucleolar recruitment factor for ciz1. Scientific Reports, October 2020. URL: http://dx.doi.org/10.1038/s41598-020-75160-z, doi:10.1038/s41598-020-75160-z. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-020-75160-z)

[13. (Coverley2005Ciz1) Dawn Coverley, Jackie Marr, and Justin Ainscough. Ciz1 promotes mammalian dna replication. Journal of Cell Science, 118(1):101–112, January 2005. URL: http://dx.doi.org/10.1242/jcs.01599, doi:10.1242/jcs.01599. This article has 68 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.01599)

[14. (Sunwoo2017Repeat) Hongjae Sunwoo, David Colognori, John E. Froberg, Yesu Jeon, and Jeannie T. Lee. Repeat e anchors xist rna to the inactive x chromosomal compartment through cdkn1a-interacting protein (ciz1). Proceedings of the National Academy of Sciences, 114(40):10654–10659, September 2017. URL: http://dx.doi.org/10.1073/pnas.1711206114, doi:10.1073/pnas.1711206114. This article has 99 citations.](https://doi.org/10.1073/pnas.1711206114)

[15. (Mitsui1999Cloning) Kaoru Mitsui, Akira Matsumoto, Satoshi Ohtsuka, Motoaki Ohtsubo, and Akihiko Yoshimura. Cloning and characterization of a novel p21cip1/waf1-interacting zinc finger protein, ciz1. Biochemical and Biophysical Research Communications, 264(2):457–464, October 1999. URL: http://dx.doi.org/10.1006/bbrc.1999.1516, doi:10.1006/bbrc.1999.1516. This article has 61 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/bbrc.1999.1516)

16. (Turvey2023Dominant) Dominant CIZ1 fragments drive epigenetic instability and are expressed in early stage cancers. This article has 1 citations.